Trial Profile
Clinical Trials Insight: 700014411
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 18 Aug 2006
Price :
$35
*
At a glance
- Drugs AMG 222 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Alantos Pharmaceuticals
- 18 Aug 2006 New trial record.